Epidemiology of Amyotrophic Lateral Sclerosis
Journal Title: Turkish Journal of Neurology - Year 2020, Vol 26, Issue 3
Abstract
There has been an increase in studies on amyotrophic lateral sclerosis (ALS) in the last thirty years. These studies show an ALS incidence rate that varies between 0.6 and 3.8 per 100,000 person-years. The incidence rate is significantly lower in Asia than in Europe and North America. ALS prevalence rates vary between 4.1 and 8.4 per 100,000. It is more common in men, and the male-to-female ratio is between 1 and 2. The mean age of ALS onset is between 51 and 66 years. Patients with familial ALS tend to have an earlier age of onset compared with patients with sporadic ALS. Some 58-82% of the cases have a spinal onset. The studies show age, male sex, and family history as risk factors. Other than these, lifestyle and exposure to environmental factors may have an effect. The period from the first symptoms to either invasive ventilatory support or death is between 24 and 50 months. ALS foci with high prevalence have been recorded in Guam, The Kii Peninsula, and New Guinea. Underdeveloped or developing countries show a speedy aging tendency, which points to an increased burden due to ALS in their future. Further epidemiologic studies with higher case numbers in different regions are needed to be able to enlighten causative associations of the disease.
Authors and Affiliations
Mehmet Rıfkı Aktekin, Hilmi Uysal
Keywords
Related Articles
- EP ID EP689418
- DOI 10.4274/tnd.2020.45549
- Views 170
- Downloads 0
Epidemiology of Multiple Sclerosis in Turkey; A Ten-Year Trend in Rural Cities
Objective: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system that principally affects young adults. Recent studies from different parts of the world have shown that the incidence an...
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to...
Neuroimaging in Developmental Coordination Disorder
Developmental coordination disorder (DCD) is a neuromotor disorder of unknown etiology characterized by motor skill disorder, which significantly inhibits the child’s ability to perform daily living activities and affect...
Effects of Body Temperature Lowering on Visual Evoked Potentials in Patients with Multiple Sclerosis
Objective: Aggravation of neurologic symptoms in patients with multiple sclerosis (MS) due to heating is well known. This phenomenon, known as Uhthoff phenomenon (UP), is explained by transient conduction block in demyel...
What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance
no summary